Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
African Swine Fever mRNA vaccine (Spirit Jinyu Biological Pharmaceutical)
- Development stage
- Preclinical
- Lead developer
- Spirit Jinyu Biological Pharmaceutical
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The African Swine Fever mRNA vaccine is a veterinary biologic being developed by Spirit Jinyu Biological Pharmaceutical (also known as Jinyu Biotechnology) for the prevention of African Swine Fever (ASF) in pigs. Utilizing mRNA-based technology, the vaccine is designed to deliver genetic instructions that cause host cells to express specific African Swine Fever Virus (ASFV) antigens. This expression triggers a robust and protective immune response, encompassing both antibody production and T-cell activation, to safeguard swine populations against this highly contagious and lethal viral disease. The project is currently in the preclinical laboratory research stage.
- Other names
- African Swine Fever mRNA VaccineASFV mRNA vaccine
02
Targets
ASFV (African swine fever virus)
Beyond the preview
Go deeper on African Swine Fever mRNA vaccine (Spirit Jinyu Biological Pharmaceutical).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on African Swine Fever mRNA vaccine (Spirit Jinyu Biological Pharmaceutical).